Which combination with warfarin requires careful monitoring for interactions?

• A. Warfarin and acetaminophen.
• B. Warfarin and aspirin.
• C. Warfarin and loratadine.
• D. Warfarin and levothyroxine.

Answer: (B)

The key idea is that warfarin’s effectiveness and safety hinge on avoiding excessive anticoagulation, which can lead to dangerous bleeding. When a drug that alters bleeding risk is added, you must monitor the combination closely, especially the INR and any signs of bleeding.

Combining warfarin with aspirin is the scenario that most clearly demands careful monitoring. Warfarin slows clotting by inhibiting vitamin K–dependent factors, while aspirin directly impairs platelet function. The two mechanisms together significantly raise the risk of major bleeding, including in the gastrointestinal tract or intracranially. Because of this heightened risk, clinicians and patients need vigilant INR checks, possible dose adjustments, and careful observation for bruising, unusual bleeding, or black stools.

Acetaminophen is generally safer with warfarin at typical doses, though high or chronic use can still affect INR in some people, so monitoring is wise if use is frequent. Loratadine has minimal interaction with warfarin and is unlikely to require intensive monitoring. Levothyroxine can influence warfarin effect if thyroid status changes, but the interaction is less pronounced than with aspirin and still warrants periodic monitoring, especially during dose changes or thyroid adjustments.